Breast Cancer Test Wins FDA Clearance

From: Marilyn Ringst (marilyncnm@hotmail.com)
Wed Jan 9 08:16:52 2002


Breast Cancer Test Wins FDA Clearance

The device was developed with the goal of better enabling physicians to detect atypical changes in cells lining the milk ducts, which is where an estimated 95 percent of all breast cancers originate, according to the company.

http://www.medicaldata.com/mit/detail.asp?art=01090205&MITUID=216694





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Dec 2 04:52:39 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.